The FDA has granted orphan drug designation to PEP-010 for pancreatic cancer, advancing its development as a potential novel ...

Pharmacogenomics. 2008;9(6):671-674. Paclitaxel (Taxol ®) has a broad activity spectrum and is clinically used, often in combination with carboplatin, to treat breast, ovarian and lung cancer.

Patients with HER2 gene amplification, normal left ventricular ejection fraction (LVEF), and resistant relapse after first- or second-line paclitaxel/carboplatin chemotherapy received paclitaxel ...

Telomir-1 shows potential in oncology and age-related diseases, with new findings on its role in tumor suppression and ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

Telomir Pharmaceuticals (TELO) announced preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a ...